Table 1.
Quantified Measure of Non-healing | Biomaterial/Method | Reference | |
---|---|---|---|
Tissue Markers: | |||
↑ β-catenin ↑ c-myc | ↑nuclear/cytoplasmic staining |
Biomaterial: debrided tissue Method: immunostaining (IHC/IF) |
14,28,29 |
↓ BMPR ↓ LRIG1 ↓ GATA3 ↓ IDR2,4 ↓ K15 |
↓ gene expression ↓ gene expression ↓ nuclear staining ↓membranous staining |
Biomaterial: debrided tissue Methods: microarray, q-PCR, IHC/IF |
14 |
↑ ADAM12 | ↑ gene expression ↑nuclear/cytoplasmic staining |
Biomaterial: debrided tissue Methods: microarray, q-PCR, IHC/IF |
96 |
EGFR | ↑ cytoplasmic staining |
Biomaterial: debrided tissue Method: IHC/IF |
3 |
↓ cathelicidin | ↓ staining wound edge, wound bed infiltrate and exudate |
Biomaterial: debrided tissue Method: IHC/IF |
97 |
tPA, uPA, PAI-1 | variable expression |
Biomaterial: debrided tissue Methods: mRNA in situ hybridization, IHC/IF |
98 |
↓ TGFβI,II,III ligands | ↓ gene expression ↓ staining |
Biomaterial: debrided tissue Methods: qPCR, IHC/IF |
99 |
↓ phospho-smad2 | ↓ nuclear staining |
Biomaterial: debrided tissue Methods: IHC/IF |
100 |
↑ miR-16, -20a, -21, -106a, -130a, -203 |
↑ expression |
Biomaterial: debrided tissue Methods: q-PCR, in situ hybridization |
80,101 |
Wound Fluid Markers: | |||
↑ MMP1, 2, 3, 7, 8, 9, 10, 11, 13 |
↑ protein expression |
Biomaterial: collected using swabbing technique or wound vac Methods: ELISA; Point-of-care qualitative measurement device available in select countries for clinical use (WOUNDCHECK™) |
15,50–54,57,58, 70 |
↓ TIMP1 | ↓ protein expression |
Biomaterial: wound fluid Methods: ELISA, quantitative gelatin zymography |
56 |
↑ MMP9: TIMP1 | ↑ protein expression MMP9 ↓ protein expression TIMP1 |
Biomaterial: collected using porous, inert hydrophilic dextranomer beads applied to the wound Methods: ELISA, quantitative gelatin zymography |
55 |
↑ IL1 ↑ IL6 | ↑ protein expression |
Biomaterial: collected directly from wound bed Methods: ELISA |
69,70 |
↓albumin ↓ total protein |
< 20g/l ↓ protein expression |
Biomaterial: collected using transparent occlusive dressing Methods: Bayer Axon clinical chemistry analyzer |
70 |